BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/21/2016 7:57:00 AM | Browse: 794 | Download: 1228
 |
Received |
|
2016-06-08 17:08 |
|
Peer-Review Started |
|
2016-06-14 11:55 |
|
To Make the First Decision |
|
2016-07-04 16:01 |
|
Return for Revision |
|
2016-07-11 11:10 |
|
Revised |
|
2016-07-20 15:30 |
|
Second Decision |
|
2016-09-05 09:39 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2016-09-18 14:51 |
|
Articles in Press |
|
2016-09-18 14:51 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2016-11-09 11:14 |
|
Publish the Manuscript Online |
|
2016-11-21 07:57 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Ophthalmology |
| Manuscript Type |
Minireviews |
| Article Title |
Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sonia Labrador-Velandia, María Luz Alonso-Alonso, Sara Alvarez-Sanchez, Jorge González-Zamora, Irene Carretero-Barrio, José Carlos Pastor, Iván Fernandez-Bueno and Girish Kumar Srivastava |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Consejería de Educación de la Junta de Castilla y León |
VA118U14 |
| Consejería de Educación de la Junta de Castilla y León |
Va040-13 |
|
| Corresponding Author |
Girish Kumar Srivastava, PhD, Prin¬cipal and Senior Investigator, Instituto Universitario de Oftalmobiología Aplicada, Universidad de Valladolid, Campus Miguel Delibes, Paseo de Belén, 17, 47011 Valladolid, Spain. girish@ioba.med.uva.es |
| Key Words |
Mesenchymal stem cells; Cell therapy; Optic nerve diseases; Clinical trials; Retinal diseases |
| Core Tip |
Advances in the knowledge of neuroprotection, immunomodulation and regenerative properties of mesenchymal stem cells (MSCs) are contributed by several preclinical studies of various neurodegenerative diseases. It has provided opportunity to perform the translation of treatment approach to the clinical practice. Several clinical trials in patients with retinal and optic nerve diseases have been developed since 2008. Most of them using MSCs are in Ⅰ/Ⅱ phase. However, there is still a long way to go to reach clinical trials Phase Ⅲ-Ⅳ. Hence, it is necessary to continue with preclinical and clinical studies to improve this new therapeutic tool. |
| Publish Date |
2016-11-21 07:57 |
| Citation |
Labrador-Velandia S, Alonso-Alonso ML, Alvarez-Sanchez S, González-Zamora J, Carretero-Barrio I, Pastor JC, Fernandez-Bueno I, Srivastava GK. Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials. World J Stem Cells 2016; 8(11): 376-383 |
| URL |
http://www.wjgnet.com/1948-0210/full/v8/i11/376.htm |
| DOI |
http://dx.doi.org/10.4252/wjsc.v8.i11.376 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
